Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AVLN compared with IMTX: revenue, margins and what each company keeps, and the suppliers and customers both name
AVLN
Avalyn Pharma Inc.
Change
Mkt cap
Revenue
Revenue
IMTX
Immatics N.V.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AVLN
Avalyn Pharma Inc.
vs
IMTX
Immatics N.V.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
AVLN: latest quarter not drawable. IMTX: latest quarter not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AVLN, solid
IMTX, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AVLN
0
None
Shared
0
No disclosed counterparties: AVLN.
Only IMTX
2
BMY
Bristol-Myers Squibb
customer
MRNA
ModernaTX
customer
Role chip = supplier or customer
Source: SEC EDGAR
AVLN
Avalyn Pharma Inc.
Change
25.42
▼
−1.14%
· post 25.18
Mkt cap
$759.9M
IMTX
Immatics N.V.
Change
7.20
▼
−1.57%
· post 7.20
Closed
Oct 30 '26
Mkt cap
$965.3M
vs
Compare
Closed
Oct 30 '26
AVLN
Avalyn Pharma Inc.
vs
IMTX
Immatics N.V.
25.42
▼
−1.14%
post 25.18
Price
7.20
▼
−1.57%
post 7.20
$759.9M
Mkt cap
$965.3M
Change
Change
AVLN
25.42
▼
−1.14%
vs
IMTX
7.20
▼
−1.57%
Closed
Oct 30 '26